Arkolith/Insider Trading/AVBP/Form 4

LaChapelle Robin

Chief Operating OfficerArriVent BioPharma, Inc. (AVBP) · full profile →Form 4 · filed Jul 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2025Option exercise(M)2K$2.28$5K127K
Jul 11, 2025Option exercise(M)7K$2.28$15K136K
Jul 11, 2025Option exercise(M)3K$2.28$6K129K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2025Option exercise(M)3K—$013K
Jul 11, 2025Option exercise(M)7K—$06K
Jul 11, 2025Option exercise(M)2K—$0410

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-067928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML